These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35183688)

  • 1. A hypothesis-driven study to comprehensively investigate the association between genetic polymorphisms in EPHX2 gene and cardiovascular diseases: Findings from the UK Biobank.
    Zhu X; Li Y; Yu T; Li S; Chen M
    Gene; 2022 May; 822():146340. PubMed ID: 35183688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study.
    Li X; Meng X; He Y; Spiliopoulou A; Timofeeva M; Wei WQ; Gifford A; Yang T; Varley T; Tzoulaki I; Joshi P; Denny JC; Mckeigue P; Campbell H; Theodoratou E
    PLoS Med; 2019 Oct; 16(10):e1002937. PubMed ID: 31626644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
    Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
    Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.
    Koerner IP; Jacks R; DeBarber AE; Koop D; Mao P; Grant DF; Alkayed NJ
    J Neurosci; 2007 Apr; 27(17):4642-9. PubMed ID: 17460077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epoxyeicosatrienoic Acids are Mediated by EPHX2 Variants and may be a Predictor of Early Neurological Deterioration in Acute Minor Ischemic Stroke.
    Yi X; Lin J; Li J; Zhou Q; Han Z
    J Atheroscler Thromb; 2017 Dec; 24(12):1258-1266. PubMed ID: 28835580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes.
    Fava C; Montagnana M; Danese E; Almgren P; Hedblad B; Engström G; Berglund G; Minuz P; Melander O
    Pharmacogenet Genomics; 2010 Feb; 20(2):94-103. PubMed ID: 20065888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No impact of soluble epoxide hydrolase rs4149243, rs2234914 and rs751142 genetic variants on the development of type II diabetes and its hypertensive complication among Jordanian patients.
    Khamees M; Jarrar Y; Al-Qirim T; Mahmoud IS; Hatmal MM; Alshaer W; Lee SJ
    Int J Clin Pract; 2021 May; 75(5):e14036. PubMed ID: 33512081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat.
    Corenblum MJ; Wise VE; Georgi K; Hammock BD; Doris PA; Fornage M
    Hypertension; 2008 Feb; 51(2):567-73. PubMed ID: 18086949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study.
    Burdon KP; Lehtinen AB; Langefeld CD; Carr JJ; Rich SS; Freedman BI; Herrington D; Bowden DW
    Diab Vasc Dis Res; 2008 Jun; 5(2):128-34. PubMed ID: 18537101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome.
    Oni-Orisan A; Cresci S; Jones PG; Theken KN; Spertus JA; Lee CR
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():15-22. PubMed ID: 30096423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of soluble epoxide hydrolase reduces post-ischemic recovery of cardiac contractile function.
    Edin ML; Gruzdev A; Bradbury JA; Graves JP; Muse GW; Goulding DR; Lih FB; DeGraff LM; Zeldin DC
    Biochem Pharmacol; 2024 Oct; 228():116237. PubMed ID: 38679211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans.
    Ramirez CE; Shuey MM; Milne GL; Gilbert K; Hui N; Yu C; Luther JM; Brown NJ
    Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():38-44. PubMed ID: 25173047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
    Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
    Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.
    Lee CR; North KE; Bray MS; Fornage M; Seubert JM; Newman JW; Hammock BD; Couper DJ; Heiss G; Zeldin DC
    Hum Mol Genet; 2006 May; 15(10):1640-9. PubMed ID: 16595607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in the human soluble epoxide hydrolase gene and recurrence of atrial fibrillation after catheter ablation.
    Wutzler A; Kestler C; Perrot A; Loehr L; Huemer M; Parwani AS; Attanasio P; Özcelik C; Schunck WH; Gollasch M; Haverkamp W; Boldt LH
    Int J Cardiol; 2013 Oct; 168(4):3647-51. PubMed ID: 23711456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the soluble epoxide hydrolase gene and preeclampsia.
    Sari I; Pinarbasi H; Pinarbasi E; Yildiz C
    Hypertens Pregnancy; 2017 Nov; 36(4):315-325. PubMed ID: 29058492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease.
    Xu Y; Ding H; Peng J; Cui G; Liu L; Cianflone K; Wang DW
    Pharmacogenet Genomics; 2011 Aug; 21(8):489-94. PubMed ID: 21642892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between EPHX2 gene polymorphisms and essential hypertension in Uygur, Kazakh, and Han.
    Zhu XL; Wang L; Wang Z; Chen SZ; Zhang WQ; Ma MM
    Genet Mol Res; 2015 Apr; 14(2):3474-80. PubMed ID: 25966114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between CYP4A11 and EPHX2 genetic polymorphisms and chronic kidney disease progression in hypertensive patients.
    Suárez-Santisteban MA; Santos-Díaz G; García-Bernalt V; Pérez-Pico AM; Mingorance E; Mayordomo R; Dorado P
    Nefrologia (Engl Ed); 2024; 44(3):382-395. PubMed ID: 38448299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
    Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
    PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.